Dr. Carrie Jose, in her latest Health and Wellness column, explains how to tell the difference between exercise-induced leg ...

The FDA has granted 510 (k) clearance to an expandable lateral lumbar interbody system. U.S. Court–Middle District Florida ...

Lower back pain can affect one's ability to move comfortably and function throughout the day. Medications, including over-the-counter (OTC) and prescription drugs, are available to manage pain and ...

Low back pain is a widespread ailment impacting millions globally. The primary reasons behind this health condition can differ and include inadequate body posture, physical injury, or muscle tension.

An archived webcast will be available on the company's website. About the Phase 2 Suzetrigine Lumbosacral Radiculopathy (LSR) Study This phase 2, 12-week, randomized, double-blind, placebo-controlled ...

announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip that radiates down the back of the thigh ...

Vertex Pharmaceuticals Incorporated VRTX announced results from its Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR), a disorder that causes pain in the lower back and hip ...

Painful lumbosacral radiculopathy, or LSR, is one of the most common causes of peripheral neuropathic pain. It is pain caused by impairment of nerve roots in the area of the lumbar spine. It often ...

Lumbosacral radiculopathy is a neurologic condition that occurs when a nerve root in the lower back is compressed or irritated. Millions of patients suffer from pain due to LSR every year.

Vertex Pharmaceuticals Inc.’s non-addictive drug helped patients with lower back pain, moving the company closer to selling an alternative to opioids in another type of pain.The mid-stage trial hit ...

An archived webcast will be available on the company's website. About the Phase 2 Suzetrigine Lumbosacral Radiculopathy (LSR) Study This phase 2, 12-week, randomized, double-blind, placebo ...